TTNP - Titan Pharmaceuticals, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 55.61M
Enterprise Value 314.43M
Trailing P/E N/A
Forward P/E 1-0.61
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)0.86
Price/Book (mrq)1.82
Enterprise Value/Revenue 32.22
Enterprise Value/EBITDA 6-1.47

Trading Information

Stock Price History

Beta (3Y Monthly) 0.58
52-Week Change 3-90.59%
S&P500 52-Week Change 30.90%
52 Week High 35.0400
52 Week Low 30.4031
50-Day Moving Average 30.9644
200-Day Moving Average 31.4315

Share Statistics

Avg Vol (3 month) 3267.57k
Avg Vol (10 day) 3363.42k
Shares Outstanding 521.2M
Float 12.93M
% Held by Insiders 14.32%
% Held by Institutions 14.99%
Shares Short (Jul 15, 2019) 41.1M
Short Ratio (Jul 15, 2019) 42.8
Short % of Float (Jul 15, 2019) 48.45%
Short % of Shares Outstanding (Jul 15, 2019) 48.13%
Shares Short (prior month Jun 14, 2019) 4958.62k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 25/1
Last Split Date 3Sep 29, 2015

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Mar 31, 2019

Profitability

Profit Margin -168.26%
Operating Margin (ttm)-156.05%

Management Effectiveness

Return on Assets (ttm)-75.78%
Return on Equity (ttm)-990.04%

Income Statement

Revenue (ttm)6.5M
Revenue Per Share (ttm)0.45
Quarterly Revenue Growth (yoy)-11.20%
Gross Profit (ttm)-1.4M
EBITDA -9.81M
Net Income Avi to Common (ttm)-11.22M
Diluted EPS (ttm)-0.7900
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.91M
Total Cash Per Share (mrq)0.44
Total Debt (mrq)5.07M
Total Debt/Equity (mrq)165.93
Current Ratio (mrq)2.12
Book Value Per Share (mrq)0.23

Cash Flow Statement

Operating Cash Flow (ttm)-11.74M
Levered Free Cash Flow (ttm)-8.06M